ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy.

ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy. Oncotarget. 2017 Oct 24; 8(51):88410-88420.

View in: PubMed